Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-05-29Clinical Trial Update: Safety Study of Radiotherapy and Concurrent Erlotinib (Tarceva®) for Brain Metastases From a Non-Small Cell Lung Cancer [Phase 1]
This Phase 1 safety study evaluates the safety of combining radiotherapy with erlotinib (Tarceva) for brain metastases in patients with non-…
-
CLINICAL_TRIALS trial_result · 2008-05-22Clinical Trial Update: Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating oxaliplatin and gemcitabine, with or without bevacizumab, for advanced non-small cell lung cancer has be…
-
CLINICAL_TRIALS research · 2008-05-22Clinical Trial Update: Neoadjuvant Chemotherapy Plus/Minus Surgery in Non-Small-Cell Lung Cancer (NSCLC) Stage IIIA/N2 [Phase 3]
This clinical trial update describes a Phase 3 study evaluating neoadjuvant chemotherapy with or without surgery for stage IIIA/N2 non-small…
-
CLINICAL_TRIALS research · 2008-05-16Clinical Trial Update: Erlotinib Versus Carboplatin/Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 clinical trial comparing erlotinib to carboplatin/vinorelbine in elderly patients with advanced non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2008-05-14Clinical Trial Update: Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating an HLA-A*0201-restricted peptide vaccine therapy in patients with non-small cell lung cancer; sponsor To…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-05-14Clinical Trial Update: Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer [Phase 1, Phase 2]
An ongoing Phase 1/2 clinical trial evaluating an HLA-A*2402 restricted peptide vaccine for non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2008-05-05Clinical Trial Update: Angiogenesis With Positron Emission Tomography (PET) Tracer Uptake
A Gunma University-sponsored trial assessing angiogenesis using a positron emission tomography tracer in non-small cell lung cancer has comp…
-
CLINICAL_TRIALS trial_result · 2008-04-30Clinical Trial Update: Ph I:Bevacizumab + Chemotherapy in Pts w/Malig Pleural Effusion Due to Adv NSCLC [Phase 1]
Phase I trial of bevacizumab plus chemotherapy for malignant pleural effusion in advanced non-small cell lung cancer; the study status is co…
-
CLINICAL_TRIALS trial_result · 2008-04-22Clinical Trial Update: Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating erlotinib for brain metastases in non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2008-04-22Clinical Trial Update: Preoperative Twice Daily Chemoradiation in Addition to Chemotherapy Prior to Surgery in Stage III Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
This document notes the completion of a Phase 3 trial assessing preoperative twice-daily chemoradiation in addition to chemotherapy before s…
-
CLINICAL_TRIALS trial_result · 2008-04-22Clinical Trial Update: Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy. [Phase 3]
A randomized Phase III trial in stage IIIb and IV non-small cell lung cancer compares sequential single-agent, double-agent, and triple-agen…
-
CLINICAL_TRIALS trial_result · 2008-04-01Clinical Trial Update: Three Combinations Of Docetaxel And Irinotecan For Recurrent Or Metastatic Non Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating three combinations of docetaxel and irinotecan in patients with recurrent or metastatic non-small cell lung cancer …
-
CLINICAL_TRIALS trial_result · 2008-03-20Clinical Trial Update: Docetaxel in Non Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 trial of docetaxel in non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2008-03-13Clinical Trial Update: Study of Alimta® (Pemetrexed) Plus VELCADE® (Bortezomib) or Alimta Alone or VELCADE Alone in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Prior Therapy [Phase 2]
Phase 2 study comparing pemetrexed plus bortezomib, pemetrexed alone, or bortezomib alone in locally advanced or metastatic non-small cell l…
-
CLINICAL_TRIALS research · 2008-03-13Clinical Trial Update: Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating concurrent helical tomotherapy with chemotherapy in patients with unresectable stage III non-small cel…
-
CLINICAL_TRIALS trial_result · 2008-03-12Clinical Trial Update: Weekly Versus 3-Weekly Docetaxel Plus Cisplatin for Advanced NSCLC [Phase 2]
Phase 2 trial comparing weekly versus every-three-weeks docetaxel plus cisplatin in advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-12Clinical Trial Update: Second-Line Irinotecan or Gefitinib in Docetaxel Pretreated NSCLC [Phase 2]
This update covers a Phase 2 trial comparing second-line irinotecan versus gefitinib in non-small cell lung cancer patients previously treat…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients With Stage III/IV and Relapsed NSCLC [Phase 2]
This clinical trial update reports the completion of a Phase II study evaluating a 96-hour continuous infusion of paclitaxel followed by cis…
-
CLINICAL_TRIALS research · 2008-03-04Clinical Trial Update: Analysis of Brain Metastasis in Patients With Lung Cancer
Completed clinical trial update analyzing brain metastasis in patients with non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non-Small Cell Lung Cancer [Phase 2]
This Phase II neoadjuvant trial of continuous infusion paclitaxel plus cisplatin, followed by chest radiotherapy, in stage III non-small cel…
-
CLINICAL_TRIALS trial_result · 2008-02-29Clinical Trial Update: Metronomic Oral Vinorelbine in Patients With Metastatic Tumors [Phase 2]
Phase 2 clinical trial update for metronomic oral vinorelbine in metastatic breast cancer, non-small cell lung cancer, and prostate cancer; …
-
CLINICAL_TRIALS research · 2008-02-28Clinical Trial Update: Study of Developing an Optimal Gemcitabine Based Regimen to Treat Elderly Patients With Advanced Non-Small Cell Carcinoma [Phase 2]
Phase 2 clinical trial update studying a gemcitabine-based regimen to treat elderly patients with advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2008-02-22Clinical Trial Update: Efficacy of Gefitinib for Brain Metastasis of Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial is evaluating Gefitinib for brain metastases in non-small cell lung cancer; the update notes the trial status as UN…
-
CLINICAL_TRIALS trial_result · 2008-02-11Clinical Trial Update: Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating VELCADE alone or with docetaxel in previously treated advanced non-small cell lung cancer has been completed. The s…
-
CLINICAL_TRIALS research · 2008-02-01Clinical Trial Update: Assess the Variability of Uni-Dimensional, Bi-Dimensional, and Volumetric CT Scan Measurement of Non-Small Cell Lung Cancer Tumors
A completed clinical study evaluating variability in uni-dimensional, bi-dimensional, and volumetric CT measurements of non-small cell lung …